Investors

    Investing in the Future of Scaleable Women's Healthcare Diagnostics

    A global MedTech ecosystem displacing expensive diagnostic imports. Built in India. Scaled for the developing world.

    Request Pitch Deck & Financial Model

    Transforming Cervical Cancer Early Detection Globally

    Cervical cancer is entirely treatable if caught early, yet traditional screening fails where it is needed most.

    94% Global Burden

    350,000 annual deaths. 94% concentrated in developing markets. The sole cause: zero access to affordable screening.

    THE LMIC CRISIS

    1–2% Screened

    Expensive, bulky imported infrastructure leaves over 98% of India's eligible population completely unscreened.

    THE INDIA PROOF POINT

    $10B+ Addressable Market

    A massive, unpenetrated global market demanding cost-effective, portable hardware paired with AI diagnostics.

    SCALABLE GLOBAL TAM

    Our Scalable Product Strategy

    High-Barrier Hardware + High-Margin AI SaaS

    We leverage proprietary hardware to anchor clinical real estate and unlock scalable SaaS revenue.

    Griva Vision

    PORTABLE COLPOSCOPE

    Proprietary, ultra-portable hardware engineered for low-cost, immediate deployment across hospitals, private clinics, and global NGOs.

    01Market-Ready

    AI Catalyst

    SOFTWARE AS A MEDICAL DEVICE (SaMD)

    Proprietary, real-time image analysis that empowers general clinicians to diagnose accurately, unlocking high-margin, global SaaS ARR.

    02In Validation

    Multi-Product Ecosystem

    EXPANDING ACCOUNT LTV

    Maximizing lifetime value with active test licenses already secured for two upcoming gynecology devices, including our next-gen Hysteroscope.

    03Pipeline

    Turnkey Market Access

    BUILT-IN DISTRIBUTION

    Bypassing traditional commercial entry barriers by leveraging our leadership's deep network of 15+ regional distributors and 200+ established hospital relationships.

    04Distribution

    Institutional Backing & Regulatory Moats

    Systematically de-risked — audited, funded, and approved by India's apex authorities.

    CDSCO Class B

    Audit Completed — critical regulatory manufacturing compliance milestone achieved.

    Startup Karnataka

    ELEVATE NxT Stage-3 Finalist — top-tier startup selected by state evaluators.

    Technology Development Board

    Successfully cleared innovation evaluation phase (TDB).

    AMTZ / AIC MediValley

    Incubated — anchored within India's leading medtech manufacturing hub.

    DPIIT Certified

    Officially recognized by the Government of India.

    Capitalize on the MedTech Scaling Wave

    Access our full financial models, detailed regulatory roadmap, and global market projections. Schedule a direct callback from our founding team.

    Request Pitch Deck & Briefing

    Get in Touch

    Interested in learning more? Send us a note and we'll share our investor deck confidentially.